V5 Ultimate
Blood & Tissue · How V5 Runs

How V5 Ultimate runs a blood centre or tissue bank, donor to recipient.

Eleven touchpoints from donor registration to recipient lookback — sharing one immutable ledger. Mapped to 21 CFR 1271, 21 CFR 606 / 630 / 640, AABB and AATB Standards, FACT-JACIE, ISBT 128 labelling, EU 2002/98/EC and 2004/23/EC, and 21 CFR Part 11.

Start free trial
21 CFR 127121 CFR 60621 CFR 630/640AABBAATBFACT-JACIEISBT 128EU 2002/98/ECEU 2004/23/EC21 CFR Part 11
ONE IMMUTABLE LEDGER21 CFR 1271 · 21 CFR 606/630/640 · AABB · AATB · FACT-JACIE · ISBT 128 · EU 2002/98/EC · EU 2004/23/EC · Part 1101DonorEligibility02CollectionDIN minted03IDMHard quarantine04Processingkiosk-led05QC releasevs spec06ISBT 128PDC = donation07Consigneecold-chainThe evidence chainEvery action signs the ledger — nothing is re-keyed at the end.
Executive summary

One ledger, every touchpoint — donor to recipient lookback in seconds.

V5 Ultimate runs a blood centre or tissue bank as one connected system. Donor record and processing record built together, IDM hard-gated quarantine, kiosk-led component split / wash / culture / cryopreserve, ISBT 128-compliant labelling, continuous cold-chain stream, and AABB / AATB / FACT-JACIE / FDA-aligned quality system all write to the same immutable, identity-verified ledger.

The pay-off is operational: processing records reviewed by exception in 20–30 min instead of hours, FDA BIMO / AABB / AATB inspections supported as queries, and a reactive-donor lookback that resolves as a query — every donation, every component, every consignee, every onward record.

This playbook walks you through 11 touchpoints and the 17 quality- and cold-chain-system modules that wrap them, grouped into 8 readable parts.

11
Donor → recipient touchpoints
8
Thematic parts
30+
Regulatory anchors
Part I

Foundations

Why donor-to-recipient lookback is the spine, and the ten-node map.

01

Why donor-to-recipient lookback is the product

In a blood centre or tissue bank, the 'lot' is a donor. Every unit you collect, process and distribute has to be traceable forward to every recipient and backward to every donor — in seconds, not days.

Floor actionscan · weigh · e-sigactor + tsSTEP 01Append-only rowDB trigger writes oncesha256STEP 02Donor + processing record snapshotfrozen at releaseWO boundSTEP 03PDF renderfrom snapshot onlydeterministicSTEP 04Inspector packexported on demand21 CFR 11STEP 05ALCOA+ lineageAttributable · Legible · Contemporaneous · Original · Accurate · + Complete · Consistent · Enduring · AvailableOne origin event. No re-keying. No reconciliation.
ALCOA+ in one picture: one origin event, replayable downstream.

Under 21 CFR 1271 (HCT/Ps), 21 CFR 606 (cGMP for Blood) and the AABB / AATB / FACT-JACIE standards that overlay them, every donation is a regulated batch with its own donor-eligibility determination, its own IDM (infectious-disease marker) panel, its own processing record, and its own consignee list. A single reactive donor — HIV, HCV, HBV, HTLV, Treponema pallidum, WNV, Zika, Chagas — fires a lookback that must touch every component made from that donation, every recipient transfused or grafted, and every facility that received product.

The hazards that drive enforcement are unambiguous: a unit released before IDM testing cleared; a deferred donor whose previous donation wasn't quarantined; an ISBT 128 label re-printed without an audit trail; a cold-chain excursion caught at month-end instead of at the moment of excursion; an SOP-of-record that doesn't match SOP-actually-followed.

V5 Ultimate builds the donor record and the processing record together. Quarantine is hard-gated until IDM clears. Lookback is a query. Cold chain is a stream. AABB, AATB, FACT-JACIE and FDA BIMO inspections all read the same record.

Regulatory anchors
  • 21 CFR 1271Human Cells, Tissues, and Cellular & Tissue-based Products
  • 21 CFR 606Current Good Manufacturing Practice for Blood and Blood Components
  • AABB StandardsStandards for Blood Banks and Transfusion Services (current ed.)
  • AATB StandardsStandards for Tissue Banking (current ed.)
02

The donor-to-recipient chain at a glance

Ten touchpoints, one record. Every node writes to the same immutable ledger.

  1. 01
    Donor
  2. 02
    Collection
  3. 03
    IDM panel
  4. 04
    Spec lock
  5. 05
    Processing WO
  6. 06
    Component build
  7. 07
    QC + release
  8. 08
    Deviation / PDI
  9. 09
    ISBT 128 label
  10. 10
    QA release
One immutable ledger underneath. Every node writes; nothing is re-keyed.

Every node carries forward donor identifier (DIN), donation eligibility decision, IDM panel, processing operator, equipment, storage location, cold-chain stream, ISBT 128 label fields and consignee from the node before it. Nothing is re-keyed; nothing is reconciled by hand to the LIS.

Part II

Donor in

Donor registration, eligibility determination, deferral, consent, collection.

03

Touchpoint 1 — Donor registration and eligibility determination

Eligibility is the spine of donor safety. Every deferral, every previous donation, every travel history, every medication is on the record.

Donor registration captures identity (with deduplication against prior donations), demographic and contact data, health-history questionnaire (DHQ — current AABB edition), travel deferral logic (vCJD, malaria, WNV-active, EID-applicable), medication deferrals, behavioural-risk deferrals, and consent. Eligibility determination is structured per 21 CFR 630 (for blood) and 21 CFR 1271 Subpart C (for HCT/Ps).

Deferrals are bounded by start / end dates. A deferred donor cannot proceed to collection; an attempt opens a deviation. Re-entry from a deferral follows the relevant FDA guidance and is recorded with the medical-director signature.

  • Unique donor identifier with deduplication
  • Structured DHQ — AABB current edition
  • Travel / medication / behavioural deferrals as bounded time intervals
  • Re-entry workflows signed by medical director
Regulatory anchors
  • 21 CFR 630Donor eligibility — blood and blood components
  • 21 CFR 1271 Subpart CDonor eligibility — HCT/Ps
  • FDA DHQ GuidanceDonor history questionnaire — current version
04

Touchpoint 2 — Collection and donation identification (DIN)

Every collection is bound to a unique donation identification number — ISBT 128-compliant, single source of truth for everything downstream.

The phlebotomist scans the donor wristband and the pre-printed DIN labels (collection bag set, pilot tubes, donor record). The collection device streams volume, flow, time and any device alarms into the record. Vital signs (hgb / Hct, BP, pulse, temperature) bind to the donation. Pre / post weights and bag-set lot are recorded.

For apheresis, the device kit lot, anticoagulant lot, separation parameters and any inter-procedural alarms are streamed in. For tissue and birth-tissue recovery, the recovery time, site, recovery technician and instruments are recorded at the kiosk.

  • DIN minted and bound to donor at the chair
  • Device stream (volume, flow, alarms) on the record
  • Pilot-tube labels generated from the same DIN — no re-key
  • Recovery site / time / technician for tissue and birth tissue
Regulatory anchors
  • 21 CFR 606.150Collection of blood — procedures
  • ISBT 128Donation Identification Number structure
05

Touchpoint 3 — IDM panel and quarantine hold

From the moment of collection, every unit is in Quarantine. It cannot move to Available until the infectious-disease marker panel is complete, in-spec, and medical-director signed.

Pilot tubes route to the testing lab; results stream back to V5 against the DIN. The panel covers HIV-1/2 (Ab + NAT), HCV (Ab + NAT), HBV (HBsAg, anti-HBc, NAT), HTLV-I/II, syphilis (Treponema pallidum), WNV NAT in season, T. cruzi (Chagas), and any pathogen on the current FDA / AABB requirements list (Zika, Babesia, CMV by indication). For HCT/Ps the panel is per 21 CFR 1271.85.

Reactive on any required marker = unit and all co-components moved to Quarantined-Reactive; donor deferred per FDA guidance; lookback workspace opens. Indeterminate / repeat-reactive workflows follow the manufacturer's algorithm and AABB requirements.

  • Hard quarantine — no override path
  • LIS stream against DIN, not a re-keyed result
  • Reactive marker auto-defers donor and opens lookback
  • Algorithm for repeat-reactive / supplemental testing built in
Regulatory anchors
  • 21 CFR 610.40Test requirements for communicable disease agents
  • 21 CFR 1271.85Donor screening tests — HCT/Ps
  • AABB 5.xRequired testing — current edition
Part III

Processing

Component separation, processing-record snapshot, kiosk-led split / wash / culture / cryopreserve.

06

Touchpoint 4 — Component / product specification

The processing spec is the SOP made operational — a versioned, signed, machine-readable record bound to the component or product code.

Each component / product spec holds: product code (ISBT 128 Product Description Code), source material (whole blood / apheresis / bone graft / birth tissue / HPC), processing routing with step-by-step instructions, in-process control plan (volume, hematocrit, platelet count, leukoreduction CFU, post-thaw recovery, viability, sterility, endotoxin), storage condition with temperature band, and the locked ISBT 128 label layout.

Effectivity is two-signature: the QA author signs the change, the medical director signs that the change is clinically appropriate. New donations pick up the new revision; in-flight donations keep the snapshot they were released against.

  • ISBT 128 PDC bound to the spec
  • Storage temperature band on the spec, enforced at every move
  • Leukoreduction / irradiation / pathogen-reduction parameters on the spec
  • Two-signature change control with medical-director clinical sign-off
Regulatory anchors
  • 21 CFR 640Additional standards for human blood and blood products
  • 21 CFR 1271 Subpart DCurrent Good Tissue Practice
  • ISBT 128 PPACProduct Description Code structure
07

Touchpoint 5 — Processing-record snapshot

Releasing a processing record takes a sha256-hashed snapshot of the spec, ISBT 128 label layout and routing. From that moment the donation carries its own copy — frozen forever.

Processing spec v3.2BOM · Routing · IPCSpec · LabelEFFECTIVE · 2-SIGSNAPon releaseWO-2026-0418Bound to Processing spec v3.2Frozen at releaseRELEASED · sha256:a4f9…runs even ifProcessing spec revisesDonor + processing record (this batch)Filled by kiosk+ IPC + dev + sigsIMMUTABLEProcessing spec v3.3 (later revision)does NOT affect WO-2026-0418
The WO carries a frozen copy of Processing spec v3.2. Later revisions don't disturb this batch.

If the spec is revised mid-shift, the donation keeps the snapshot it was released against. The inspector sees exactly the spec, label and routing this donation was processed to.

Regulatory anchors
  • 21 CFR 606.160Records — content and retention
  • 21 CFR Part 11Electronic records and signatures
08

Touchpoint 6 — Kiosk-led split, wash, culture, cryopreserve

The kiosk is the lab's single pane of glass. Every centrifuge cycle, every wash, every culture passage, every cryopreservation step is signed and timestamped.

The processor scans the DIN, picks the spec, follows the routing. Equipment (centrifuge, sterile dock, plasma extractor, cell processor, controlled-rate freezer, LN₂ vapour storage) streams setpoints and actuals into the record. Reagent and consumable lots are scanned at the step — using an expired or off-spec consumable hard-stops the step.

For cellular therapy (HPC, CAR-T) the kiosk surfaces FACT-JACIE-aligned checks: cell count, viability, sterility hold, mycoplasma, endotoxin, identity / potency where required, with two-person witness on critical handovers.

  • Equipment stream — no key-in for setpoints / actuals
  • Reagent / consumable lot scanned at the step
  • Two-person witness on critical handovers
  • Cryopreservation cooling curve captured against the spec
Regulatory anchors
  • 21 CFR 606.65Supplies and reagents
  • FACT-JACIECellular therapy — manipulation standards
  • USP <1046>Cell and gene therapy products
09

Touchpoint 7 — In-process and finished-product QC

QC plans run on a schedule, not a reminder. Results flow back to the same processing record automatically.

Volume / weight, hemoglobin / hematocrit, platelet count, leukocyte residual (post-LR), pH (platelets), sterility (BacT/ALERT, Bactec), endotoxin (LAL), mycoplasma, viability and recovery (post-thaw) — all scheduled by the spec. OOS auto-opens a deviation, holds the unit and notifies QA / medical director.

Regulatory anchors
  • 21 CFR 610General biological products standards
  • AABB 6.xProcess control and product quality monitoring
Part IV

Quality events

Reactive donor, post-donation information, adverse reactions, deviations — one queue.

10

Touchpoint 8 — Deviations, post-donation information and CAPA in one queue

Every event lands in the same queue — reactive marker, post-donation information (PDI), adverse reaction in donor or recipient, processing deviation, cold-chain excursion.

Post-donation information — a donor calls in a new symptom, a new diagnosis, a new exposure after donation — is structured intake bound to the DIN. The system surfaces every component and every consignee at risk and starts the lookback / market-withdrawal clock per FDA guidance. Donor adverse reactions and recipient transfusion reactions are first-class objects with the AABB-required fields.

CAPAs link to the deviation, affected donations, processors, equipment, consignees and the change-control workspace where indicated.

Regulatory anchors
  • 21 CFR 606.171Reporting of product deviations
  • 21 CFR 600.14Biological product deviation reporting
  • AABB 7.xNonconforming products and services
Part V

Release & distribution

Hard-gated release, ISBT 128 labelling, cold-chain push, recall in seconds.

11

Touchpoint 9 — ISBT 128 labelling and final disposition

The final ISBT 128 label is generated by V5 from the locked spec, against the DIN, on the moment of release. Hand-typed labels and Word artwork don't exist.

The label carries: Donation Identification Number, Product Description Code (PDC), expiry date / time, ABO/Rh and special attributes (irradiated, leukoreduced, CMV-negative, HbS-negative, washed, frozen), facility identifier, and consignee fields where the destination is known. Re-print events (smudge, peel-failure) are signed, reason-coded and traceable to the original — the donor record shows every label that ever existed for that DIN.

  • ISBT 128 Data Identifiers and PDC structurally enforced
  • ABO/Rh and special attributes generated from the verified record
  • Re-print events signed, reason-coded, audited
  • Distribution gates on consignee approval and storage capability
Regulatory anchors
  • ISBT 128 StandardLabelling of MPHO — Data Identifiers + PDC
  • 21 CFR 606.121Container label
12

Touchpoint 10 — Hard-gated release

A unit cannot move from Quarantine to Available until the system is satisfied. No exceptions, no overrides without recorded reason and medical-director sign-off.

Release requires: complete IDM panel in-spec, in-process QC in-spec, no open deviations on the unit, storage continuously in-spec since collection, and two qualified e-signatures (typically QA + medical director). The release button is greyed until all conditions are met; an attempted override opens a deviation and notifies the medical director.

Regulatory anchors
  • 21 CFR 606.165Distribution and receipt — procedures and records
  • 21 CFR Part 11.50/70Signed records, signature-to-record linking
13

Touchpoint 11 — Distribution, consignee surface, lookback / recall in seconds

Recall and lookback are queries, not projects. Forward from a reactive donor, backward from a recipient.

Recall / withdrawal lookback timelineFrom trigger to drafted regulator report — measured in minutes, not weeksT+0sReactive donor / PDIQA opens lookbackSTEP 01T+12sAll donationsFrom this donor — every DINSTEP 02T+45sAll componentsFrom every DIN — every PDCSTEP 03T+2mAll consigneesBy DIN + componentSTEP 04T+10mBPDR + notificationsAuto from ledgerSTEP 05Bidirectional from any node — unit ⇄ case ⇄ pallet ⇄ batch ⇄ lot ⇄ supplier
One ledger, one query. Forward and backward from any node.

Every unit is shipped against a packing slip that carries the DIN, PDC, ABO/Rh, special attributes, expiry, and cold-chain envelope. Consignees acknowledge receipt and confirm storage. When a reactive marker, a PDI or a recipient adverse reaction fires a lookback, V5 walks the ledger in both directions in seconds: every donation from this donor, every component made, every consignee, every onward transfusion / graft record (where the consignee writes back).

Where the recall meets FDA's reporting threshold, the BPDR (Biological Product Deviation Report) and any 21 CFR 803-style adverse reaction report assemble from the same ledger.

Regulatory anchors
  • 21 CFR 600.14Biological product deviation reporting
  • 21 CFR 606.171Reporting of product deviations
  • FDA Lookback GuidanceRecipient notification for HIV / HCV / HBV positive donors
Part VI

Quality system

QMS, documents, training, management review, AABB / AATB / FDA inspections.

14

Quality system — AABB / AATB / FACT-JACIE / ISO 9001 as a live object

The quality system is the operating shell around the regulated work. V5 holds it as a structured, signed, live record.

Quality manual, scope, interested parties, risks-and-opportunities, objectives, processes, KPIs — all structured. Internal audit, management review and CAPA are live workspaces, not Word documents. Standards-mapping for AABB, AATB, FACT-JACIE and (where applicable) ISO 9001 lives on the same record.

Regulatory anchors
  • AABB 1.x–9.xQuality system essentials
  • AATB StandardsTissue banking quality system
  • FACT-JACIECellular therapy quality management
15

Document control — controlled, versioned, two-signature

Every SOP, work instruction, label artwork, processing spec and validation report is a controlled record.

Draft → Review → Approved → Effective → Periodic Review → Superseded / Retired. Two qualified signatures effect every release. Operators see only the effective revision; superseded revisions are retained per 21 CFR 606.160 (typically 10 years for blood records) and per AABB / AATB retention rules (often through donation expiry + traceability period).

Regulatory anchors
  • 21 CFR 606.160(d)Records retention — 10 years (blood)
  • AABB 9.xDocuments and records
16

Training and competency — kiosk-gated

If you're not trained — and competency-assessed — on the step, the kiosk won't let you advance it.

V5 maintains a training matrix per role × procedure × competency assessment. Annual competency reassessment is calendar-bounded; an expired assessment locks the operator out of the relevant kiosk action. Competency observations and re-training are first-class records.

Regulatory anchors
  • 21 CFR 606.20Personnel — qualifications and training
  • AABB 3.xPersonnel — qualification and training
17

Management review — assembled continuously, signed periodically

Management review is not a quarterly scramble. V5 assembles it continuously from the ledger.

Management Review — continuous compilationEvery batch, IPC, OOS, deviation and complaint feeds the review as it happensJanbatch · IPCFebbatch · IPCMarbatch · IPCAprbatch · IPCMaybatch · IPCJunbatch · IPCJulbatch · IPCAugbatch · IPCSepbatch · IPCOctbatch · IPCNovbatch · IPCDecbatch · IPCManagement ReviewTrends · CpK · OOS · CAPAStability · Complaints · PVAABB 1.xCpK trend chartOOS / CAPA registerStability projectionSigned review PDF
Management Review assembles continuously — not a 4-week scramble at year end.

Every donation's quality signals, every CAPA, every BPDR, every consignee complaint, every supplier scorecard, every internal-audit finding — all stream into the management-review workspace as they happen.

Regulatory anchors
  • AABB 1.xQuality management — management review
  • ISO 9001:2015 §9.3Management review (where in scope)
18

Internal audits, FDA / AABB / AATB inspections, customer audits

Audits land in the same queue as deviations. Findings drive CAPAs; CAPAs drive effectiveness checks.

V5 schedules internal audits, AABB and AATB assessments, FDA BIMO and CBER inspections, FACT-JACIE inspections (where in scope) and customer / consignee audits. When the inspector arrives, the request list — donor records, IDM testing, processing records, training, calibration, lookback files, BPDR log — is a query, assembled and printable in minutes.

Regulatory anchors
  • 21 CFR 600.21Inspections — biologic establishments
  • AABB AssessmentAABB assessor process — current edition
Part VII

Risk & operations

Cold-chain CCPs, sanitation, equipment calibration, EMP, lookback, complaints.

19

Cold chain — CCPs with auto-quarantine

Storage and shipping temperatures are continuous streams. Excursions auto-hold affected units and open a deviation — they don't wait for month-end review.

Every refrigerator, freezer, platelet incubator, LN₂ tank and shipping container is a tracked asset with product-specific temperature limits, sensor stream, alarm thresholds and excursion criteria. An excursion of duration × magnitude beyond the product spec auto-holds affected units, opens a deviation, and notifies the on-call medical director.

  • Continuous sensor stream per asset — not a daily reading
  • Product-specific excursion limits (RBC, platelet, plasma, tissue, HPC)
  • Auto-hold on excursion — no human re-keying needed
  • Shipping-container excursion linked to consignee and BOL
Regulatory anchors
  • 21 CFR 606.122Instruction circular — storage temperatures
  • AABB 5.xStorage and distribution requirements
20

Sanitation, environmental monitoring and aseptic technique

Sterile / aseptic processing is a controlled environment. V5 holds the EMP as a structured, scheduled, trended record.

Environmental Monitoring Plan (EMP) per ISO 14644 / USP <1116> where applicable: viable air, surface, personnel and water sampling at scheduled frequency, trending vs. action / alert limits, excursion linkage to affected lots. Cleaning and disinfection cycles are kiosk-led and signed.

Regulatory anchors
  • USP <1116>Microbiological control and monitoring of aseptic processing environments
  • ISO 14644Cleanrooms — classification and monitoring
21

Equipment and calibration — scales, centrifuges, freezers, analytical

Every instrument that monitors a critical control has a calibration schedule and an out-of-tolerance procedure.

Scales, centrifuges, sterile-connect devices, plasma extractors, cell processors, controlled-rate freezers, LN₂ vapour systems, hemocytometers, flow cytometers, BacT culture systems, LAL readers — each is a tracked asset with calibration interval, certificate, tolerance, and an out-of-tolerance impact assessment that triggers a back-look across every donation since the last passing calibration.

Regulatory anchors
  • 21 CFR 606.60Equipment — observation and inspection
  • AABB 4.xEquipment qualification, validation and maintenance
22

Donor health surveillance — adverse donor reactions

Donor reactions (vasovagal, hematoma, citrate toxicity) are tracked as quality signals — not just clinical notes.

Reactions are structured intake against the DIN, with severity classification per AABB. Recurring reactions per chair, per phlebotomist, per device are trended. Donor follow-up is a tracked record.

Regulatory anchors
  • AABB 7.xDonor adverse reactions — classification and follow-up
23

Lookback — built into the data, not assembled in Excel

A reactive marker, a PDI, a recipient adverse reaction — each fires a structured lookback. The candidate list is a query, not a binder hunt.

Forward genealogy from donor → donation → components → consignees → onward records walks the ledger in seconds. Consignee notification letters draft from the same ledger; acknowledgements come back to the same record. Where required, recipient notification is structured per FDA Lookback Guidance.

Regulatory anchors
  • 21 CFR 610.46HCV lookback
  • 21 CFR 610.47HIV lookback
  • FDA GuidanceLookback / recipient notification — current versions
24

Clinician and consignee feedback — every report links to a unit

A transfusion reaction, a graft failure, a label legibility issue, a kit defect — each is structured intake.

Intake captures DIN, PDC, consignee, clinician, observed effect, severity, recipient identifier where available. V5 binds the report to the donation, surfaces adjacent units and donations, and routes BPDR-eligible events to the regulatory affairs workspace.

Regulatory anchors
  • 21 CFR 606.170Adverse reaction file
Part VIII

Compliance & onboarding

Part 11 evidence, clinician / consignee surface, onboarding, regulatory matrix.

25

21 CFR Part 11 alignment — a property of the ledger

Blood and tissue records under 21 CFR 606 / 1271 are routinely electronic; Part 11 alignment is how V5 makes those records defensible.

Every signed event carries the actor's verified identity, signature meaning, time, and a sha256 of the record. The signature row is append-only. PDF renders are deterministic from the snapshot.

Regulatory anchors
  • 21 CFR Part 11Electronic records and signatures
  • ALCOA+Data-integrity principles
26

Clinician / consignee surface — portal access

Consignee hospitals, transplant centres and graft recipients query the ledger through a scoped portal.

Unit history by DIN, current cold-chain envelope, recall / lookback notifications, BPDR notifications — all on the portal. Audit-trail of who viewed what is automatic.

27

Onboarding and support — weeks, not quarters

V5 ships pre-configured for a typical blood centre / tissue bank: 21 CFR 606 / 1271 templates, ISBT 128 PDC catalogue, AABB / AATB / FACT-JACIE overlays.

A typical centre onboards in 6–12 weeks: master data import, donor-record migration, kiosk training, parallel-run validation, cutover. The validation pack (URS → IQ → OQ → PQ) is built in.

28

Regulatory matrix — every clause, every touchpoint

Where every clause lands in the V5 product surface.

Abbreviated mapping. Each link opens the full readiness guide.

RegulationScopeTouchpointsGuide
21 CFR 1271HCT/Ps — registration, eligibility, GTPAllRead →
21 CFR 606cGMP for Blood and Blood ComponentsAll
21 CFR 630Donor eligibility — blood03, 05
21 CFR 640Additional standards — blood products06, 11
21 CFR 610.40Communicable disease testing05
21 CFR 610.46/47HCV / HIV lookback23
21 CFR 600.14Biological product deviation reporting10, 13
AABB StandardsBlood Banks and Transfusion ServicesAll
AATB StandardsTissue BankingAll
FACT-JACIECellular therapy accreditation06, 08, 14
ISBT 128MPHO labelling standard04, 11
EU 2002/98/ECEU Blood DirectiveAllRead →
EU 2004/23/ECEU Tissues and Cells DirectiveAllRead →
21 CFR Part 11Electronic records / signatures07, 08, 12, 25Read →

See the playbook running on your floor.

Free trial, no credit card, onboard in days, not months.